-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Sundial Growers Stock Is Gearing up for What Could Be a Banner 2022
Sundial is stuck in a trading range, trading as a penny stock, as investors wait for its acquisitions to add meaningfully.
Sundial Stock Seems Way Overdue for a Big Rally Soon
SNDL stock looks poised for upside with ample cash buffer for investments. Growth of own brand and acquisitions to drive cash flow upside.
Why Tilray Investors Shouldn’t Bet on the U.S. Legalizing Marijuana
While the federal legalization of cannabis is a commonly cited potential catalyst for TLRY stock, investors shouldn’t count on it.
Cannabis Stocks: Why TLRY, CRON, ACB, SNDL Stocks Are Getting High Today
Today, news of what could potentially be a big legislative win, as well as the recent infrastructure bill news, is boosting cannabis stocks.
CGC Stock Alert: What Is Going on With Canopy Growth Today?
Today's earnings report for Canopy Growth Corp. has sent shares of CGC stock plummeting as investors avoid the cannabis sector altogether.
Liquor Business Acquisition Adds Value to Sundial Growers
SNDL stock has had trouble getting and staying above the key $1 level, but Sundial's strategic investments should spur some buying activity.
Politics Alone Isn’t Going To Stoke Gains in Pot-stock Sundial Growers
Although the political backdrop seems very favorable for SNDL stock, the reality could be that no one wants to touch this hot potato.
TLRY Stock: Why Meme Traders Should Buy the Dip In Tilray
TLRY stock has plummeted since it was pumped to $67 in February. Tilray is one of the few meme stocks investors should be buying on the dip.
Sundial Growers’ Latest Move Solidifies Overall Business
Sundial Growers acquired Alcanna, a Canadian operator of liquor and cannabis stores. SNDL stock jumped. What does it mean for business?
It’s Only a Matter of Time Before Sundial Stock Rallies
There are plenty of potential upcoming catalysts for SNDL stock, as management continues to craft value-creating deals for Sundial Growers.
Sundial’s Alcanna Acquisition Could Be a Game-Changer
Investors haven't given SNDL stock its due following the company's impressive turnaround. A recent acquisition could change that.
Why It’s Worth Betting Against Tilray Stock
TLRY stock will lose more money for investors as Tilray's losses mount and the stock gets diluted in the longer term.
Could Sundial Growers Win Where Aurora Cannabis Failed?
Should SNDL stock investors expect Sundial Growers to enjoy better success than Aurora Cannabis had at managing investment portfolios?
The Tilray Roller Coaster Is Set To Climb Once Again
TLRY stock is not one for the faint of heart. However, the signs are lining up for another solid rally in Tilray to close out 2021.
SNDL Stock Alert: What Is Going on With Sundial Growers Today?
Today, a number of catalysts are taking investors in SNDL stock on a nice ride higher amid an otherwise flat day in the market.
Tilray Will Need to Break the Bank to Achieve Its Revenue Target
Tilray continues to burn through its cash reserves to achieve its improbable $4 billion revenue target. But where does that leave TLRY stock?
Wait for Sundial’s Acquisitions to Pay Off Before Making a Buy
Sundial has made some interesting acquisitions, but it's best to wait for its next earnings results before placing your bets on SNDL stock.
Investors Losing Patience as Tilray Waits for Washington To Make Big Move
Without a clear timeline for cannabis legalization in the United States, TLRY stock is a long-term hold for only the most patient investors.
TLRY, SNDL, CGC, ACB: What Is Going on With Cannabis Stocks Today?
Despite disappointing earnings results from Tilray, cannabis stocks are on the move higher. Here's what investors should know.
